See the latest news and media coverage for BioCrine. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing diabetes treatments and cell imaging technology
biocrine.comLast updated
In short: BioCrine highlighted advances in islet transplantation, stem cell therapy, and eye-based diabetes technologies.
Researchers at Karolinska Institutet developed the method to enhance insulin-producing cell survival during procedures, with findings appearing in Signal Transduction and Targeted Therapy.
The gathering takes place at the Rolf Luft Research Centre in Solna, with registration required by June 25.
Researchers at Karolinska Institutet and KTH have developed an improved method for creating insulin-producing cells from human stem cells.
Funding advances technology transplanting islets into eye's anterior chamber for diabetes drug screening.
Track BioCrine and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BioCrine and other trending companies.
